Modern on Thursday topped estimates for first-quarter earnings and revenue and posted a surprise quarterly profit despite lower demand for Covid vaccines, the only marketable product. The biotech posted revenue of $1.9 billion in the first quarter, driven by Covid-shot earnings pushed back from 2022. That’s more than 60% down from the $6.1 billion it …
Category Archives: Health
Costs, what you need to learn about Shopper Well being Spinoff
Johnson & Johnson products on a shelf in a store in New York. Luca Jackson | Reuters Johnson & Johnson’s Consumer health company Kenvue valued its IPO Wednesday at $22 per share, at the high end of its quoted range, in a boosted deal that would raise about $3.8 billion. At this IPO price, the …
Continue reading “Costs, what you need to learn about Shopper Well being Spinoff”
Eli Lilly therapy with donanemab slowed illness development
An Eli Lilly and Company pharmaceutical manufacturing facility is pictured at 50 ImClone Drive on March 50, 2021 in Branchburg, New Jersey. Fresh Mike | Reuters The Alzheimer’s treatment Donanemab, which is manufactured by Eli Lillisignificantly slowed the progression of the mind-numbing disease, according to clinical trial data released by the company on Wednesday. Patients …
Continue reading “Eli Lilly therapy with donanemab slowed illness development”
Pfizer (PFE) Quarterly Report 2023
Pfizer on Tuesday reported first-quarter sales and adjusted earnings that beat Wall Street expectations, despite a decline in sales attributed to lower demand for the company’s Covid vaccine. Shares of the pharmaceutical giant were largely unchanged on Tuesday. Shares are down more than 23% for the year through Monday’s close, putting the company’s market value …
Scientists are creating an AI system that focuses on changing ideas into textual content
Alex Huth (left), Shailee Jain (center) and Jerry Tang (right) prepare to collect brain activity data at the University of Texas Biomedical Imaging Center at Austin. The researchers trained their semantic decoder using dozens of hours of participants’ brain activity data collected in an fMRI scanner. Photo: Nolan Zuk/University of Texas at Austin. Scientists have …
Sufferers might wait years for brand new medication
Juanmonino | E+ | Getty Images Seniors with early Alzheimer’s disease will face major hurdles to get treated even if promising new drugs roll out more broadly in the coming years, putting them at risk of developing more severe disease as they wait months or perhaps years for a diagnosis. The U.S. health-care system is …
Continue reading “Sufferers might wait years for brand new medication”
Eli Lilly weight reduction drug tirzepatide knowledge launched
patients who have taken Eli Lilli‘s weight-loss drug, Tirzepatide, lost an average of up to 34 pounds, or 16% of her body weight, the company said in clinical trial results released Thursday. Eli Lilly plans to complete its application for approval of the drug by the Food and Drug Administration in the coming weeks, and …
Continue reading “Eli Lilly weight reduction drug tirzepatide knowledge launched”
Carl Icahn slams Illumina’s Q1 outcomes and cost-cutting plan
Carl Icahn speaks at Delivering Alpha in New York on September 13, 2016. David A Grogan | CNBC Carl Icahn called on Friday illuminas first-quarter results were “very disappointing” and slammed the DNA sequencing company’s new cost-cutting plans. The activist investor, which owns a 1.4% stake in Illumina, is in a heated proxy battle with …
Continue reading “Carl Icahn slams Illumina’s Q1 outcomes and cost-cutting plan”
Merck (MRK) Earnings Report Q1 2023
note on Thursday reported first-quarter sales and adjusted earnings that beat Wall Street expectations, despite a sharp drop in sales of its Covid antiviral treatment molnupiravir. Sales of molnupiravir collapsed to $392 million during the period, down 88% from the $3.2 billion reported for the first quarter of 2022. Merck said the decline was primarily …
Eli Lilly (LLY) Q1 Income 2023
Medical bottles and syringes with the logo of Eli Lilly and Company are seen on a screen in the background in this illustrative photo taken in Krakow, Poland, on November 10, 2022. Jakub Porzycki | Nurphoto | Getty Images Eli LilliFirst-quarter results missed expectations on Thursday, but the drug company raised its full-year guidance. Before …